摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl N-[6-[1,5-dioxa-9-thiaspiro[5.5]undecan-11-yl-[6-[(2-methylpropan-2-yl)oxycarbonylamino]hexyl]amino]hexyl]carbamate | 239064-14-3

中文名称
——
中文别名
——
英文名称
tert-butyl N-[6-[1,5-dioxa-9-thiaspiro[5.5]undecan-11-yl-[6-[(2-methylpropan-2-yl)oxycarbonylamino]hexyl]amino]hexyl]carbamate
英文别名
——
tert-butyl N-[6-[1,5-dioxa-9-thiaspiro[5.5]undecan-11-yl-[6-[(2-methylpropan-2-yl)oxycarbonylamino]hexyl]amino]hexyl]carbamate化学式
CAS
239064-14-3
化学式
C30H57N3O6S
mdl
——
分子量
587.865
InChiKey
LUYMNDGCTOECJX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.2
  • 重原子数:
    40
  • 可旋转键数:
    19
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.93
  • 拓扑面积:
    124
  • 氢给体数:
    2
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    tert-butyl N-[6-[1,5-dioxa-9-thiaspiro[5.5]undecan-11-yl-[6-[(2-methylpropan-2-yl)oxycarbonylamino]hexyl]amino]hexyl]carbamate三异丙基硅烷茴香硫醚三氟乙酸 作用下, 反应 1.0h, 以50%的产率得到N'-(6-aminohexyl)-N'-(1,5-dioxa-9-thiaspiro[5.5]undecan-11-yl)hexane-1,6-diamine
    参考文献:
    名称:
    4-Heterocyclohexanone-Based Inhibitors of the Serine Protease Plasmin
    摘要:
    Three inhibitors that are based upon a 4-heterocyclohexanone nucleus were synthesized and evaluated for activity against the serine protease plasmin. Inhibitors of plasmin have potential as cancer chemotherapeutic agents that act by blocking both angiogenesis and metastasis. Inhibitor 1 has moderate activity against plasmin but shows good selectivity for this enzyme compared to other serine proteases including trypsin, thrombin, and kallikrein. Inhibitor 2 shows both good activity and selectivity for plasmin. Inhibitor 3, which does not incorporate an aminohexyl group that can interact with the S1 subsite, has poor activity. These results, along with previous work, demonstrate that the 4-heterocyclohexanone nucleus can effectively serve as the basis for designing inhibitors of both serine and cyst;eine proteases.
    DOI:
    10.1021/jm990110k
  • 作为产物:
    参考文献:
    名称:
    4-Heterocyclohexanone-Based Inhibitors of the Serine Protease Plasmin
    摘要:
    Three inhibitors that are based upon a 4-heterocyclohexanone nucleus were synthesized and evaluated for activity against the serine protease plasmin. Inhibitors of plasmin have potential as cancer chemotherapeutic agents that act by blocking both angiogenesis and metastasis. Inhibitor 1 has moderate activity against plasmin but shows good selectivity for this enzyme compared to other serine proteases including trypsin, thrombin, and kallikrein. Inhibitor 2 shows both good activity and selectivity for plasmin. Inhibitor 3, which does not incorporate an aminohexyl group that can interact with the S1 subsite, has poor activity. These results, along with previous work, demonstrate that the 4-heterocyclohexanone nucleus can effectively serve as the basis for designing inhibitors of both serine and cyst;eine proteases.
    DOI:
    10.1021/jm990110k
点击查看最新优质反应信息

文献信息

  • 4-Heterocyclohexanone-Based Inhibitors of the Serine Protease Plasmin
    作者:Tanya C. Sanders、Christopher T. Seto
    DOI:10.1021/jm990110k
    日期:1999.7.1
    Three inhibitors that are based upon a 4-heterocyclohexanone nucleus were synthesized and evaluated for activity against the serine protease plasmin. Inhibitors of plasmin have potential as cancer chemotherapeutic agents that act by blocking both angiogenesis and metastasis. Inhibitor 1 has moderate activity against plasmin but shows good selectivity for this enzyme compared to other serine proteases including trypsin, thrombin, and kallikrein. Inhibitor 2 shows both good activity and selectivity for plasmin. Inhibitor 3, which does not incorporate an aminohexyl group that can interact with the S1 subsite, has poor activity. These results, along with previous work, demonstrate that the 4-heterocyclohexanone nucleus can effectively serve as the basis for designing inhibitors of both serine and cyst;eine proteases.
查看更多